Evidence map›Paper›PMID 25270922›Full record

ArticleMethods in molecular biology (Clifton, N.J.)2014

Mitochondrial metabolomics using high-resolution Fourier-transform mass spectrometry.

Young-Mi Go, Karan Uppal, Douglas I Walker, ViLinh Tran, Lauriane Dury, Frederick H Strobel, Hélène Baubichon-Cortay, Kurt D Pennell, James R Roede, Dean P Jones

Abstract read
In one paragraph

Article in Methods in molecular biology (Clifton, N.J.), 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
7.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 43 citations in OpenAlex.

  1. Trial
  2. Review
  3. The Peptide Fractions of Cheddar Cheese Made withFoods (Basel, Switzerland) · 2023
    Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Omics Integration for Mitochondria Systems Biology.Antioxidants & redox signaling · 2020
    Review
  12. Review
  13. Article
  14. Metabolomic Responses to Manganese Dose in SH-SY5Y Human Neuroblastoma Cells.Toxicological sciences : an official journal of the Society of Toxicology · 2019
    Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Putrescine as indicator of manganese neurotoxicity: Dose-response study in human SH-SY5Y cells.Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association · 2018
    Article
  20. Biomonitoring in the Era of the Exposome.Environmental health perspectives · 2017
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Young-Mi GoClinical Biomarkers Laboratory, Division of Pulmonary, Allergy and Critical Care Medicine, Department of Medicine, Emory University, 615 Michael Street, Atlanta, GA, 30322, USA.
Karan Uppal
Douglas I Walker
ViLinh Tran
Lauriane Dury
Frederick H Strobel
Hélène Baubichon-Cortay
Kurt D Pennell
James R Roede
Dean P Jones
Emory University · USStructural and Molecular Basis of Infectious Systems · FRTufts University · US

Funding

Graduate and Postdoctoral Training in ToxicologyT32ES012870 · NIEHS · EMORY UNIVERSITY · PI Carmen Joseph Marsit · 2004 to 2026
$9.1M
PROJECT 3: METABOLOMIC BIOMARKERS OF PARKINSON'S DISEASEP01ES016731 · NIEHS · EMORY UNIVERSITY · PI MILLER, GARY W · 2008 to 2012
$6.7M
Metabolomics of subclinical and clinical cardiovascular diseaseP20HL113451 · NHLBI · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 2012 to 2016
$4.3M
Thioredoxin-2 protection against mitochondrial oxidative toxicityR01ES009047 · NIEHS · EMORY UNIVERSITY · PI JONES, DEAN PAUL · 1998 to 2013
$3.9M
A metabolomic model of aging in the common marmosetR01AG038746 · NIA · EMORY UNIVERSITY · PI JONES, DEAN PAUL, PROMISLOW, DANIEL EDWARD · 2010 to 2014
$2.5M
Cytoplasmic-nuclear redox signaling: Disruption by dietary cadmium levelsR01ES023485 · NIEHS · EMORY UNIVERSITY · PI GO KANG, YOUNG-MI, JONES, DEAN PAUL · 2014 to 2018
$1.8M
NHLBI NIH HHS HL113451NHLBI NIH HHS P20 HL113451NIAID NIH HHS HHSN272201200031CNIA NIH HHS AG038746NIA NIH HHS R01 AG038746NIEHS NIH HHS ES009047NIEHS NIH HHS ES016731NIEHS NIH HHS ES023485NIEHS NIH HHS P01 ES016731NIEHS NIH HHS R01 ES009047NIEHS NIH HHS R01 ES023485NIEHS NIH HHS T32 ES012870PHS HHS HHSN2722 01200031C
6 · The paper itself

Abstract

High-resolution Fourier-transform mass spectrometry (FTMS) provides important advantages in studies of metabolism because more than half of common intermediary metabolites can be measured in 10 min with minimal pre-detector separation and without ion dissociation. This capability allows unprecedented opportunity to study complex metabolic systems, such as mitochondria. Analysis of mouse liver mitochondria using FTMS with liquid chromatography shows that sex and genotypic differences in mitochondrial metabolism can be readily distinguished. Additionally, differences in mitochondrial function are readily measured, and many of the mitochondria-related metabolites are also measurable in plasma. Thus, application of high-resolution mass spectrometry provides an approach for integrated studies of complex metabolic processes of mitochondrial function and dysfunction in disease.

Indexed as

AnimalsChromatography, LiquidFemaleFourier AnalysisHumansMaleMass SpectrometryMetabolomicsMiceMitochondria, Liver

Identifiers

PMID25270922
PMCPMC4318503
OpenAlexW2411122904

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.